Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 2, 2025
Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights
Elaina Coleborn, Raluca Ghebosu, Joy Wolfram, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
July 23, 2025
Antitumor activity of violacein in osteosarcoma, neuroblastoma and triple-negative breast cancer spheroids
Beatriz Aires-Lopes, Elaina Coleborn, Fernando Souza-Fonseca-Guimarães, et al.
Trends in Immunology
|
May 20, 2026
Beyond the bench: teaching grant writing in immunotherapy training
Graham Leggatt, Janin Chandra, Zhian Chen, et al.
Journal of Extracellular Vesicles
|
September 30, 2025
Lipoprotein Association Fluorometry (LAF) as a Semi-Quantitative Characterization Tool to Assess Extracellular Vesicle-Lipoprotein Binding
Raluca Ghebosu, Jenifer Pendiuk Goncalves, Nur Indah Fitri, et al.
Cancer Immunology, Immunotherapy : CII
|
March 30, 2024
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Andrew N Wilkinson, Rui Chen, Elaina Coleborn, et al.
Nature Communications
|
November 14, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation
Timothy R McCulloch, Gustavo R Rossi, Louisa Alim, et al.
Molecular Therapy Oncolytics
|
October 2, 2023
miR-146a inhibits ovarian tumor growth <i>in vivo</i> via targeting immunosuppressive neutrophils and enhancing CD8<sup>+</sup> T cell infiltration
Rui Chen, Elaina Coleborn, Chintan Bhavsar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy
Louisa Alim, Siddharth Adityan, Rui Chen, et al.
Clinical and Translational Medicine
|
January 7, 2025
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR
Pui Yeng Lam, Natacha Omer, Josh K M Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 3, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
Joshua K M Wong, Pui Yeng Lam, Elaina Coleborn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 2, 2025
Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights
Elaina Coleborn, Raluca Ghebosu, Joy Wolfram, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
July 23, 2025
Antitumor activity of violacein in osteosarcoma, neuroblastoma and triple-negative breast cancer spheroids
Beatriz Aires-Lopes, Elaina Coleborn, Fernando Souza-Fonseca-Guimarães, et al.
Trends in Immunology
|
May 20, 2026
Beyond the bench: teaching grant writing in immunotherapy training
Graham Leggatt, Janin Chandra, Zhian Chen, et al.
Journal of Extracellular Vesicles
|
September 30, 2025
Lipoprotein Association Fluorometry (LAF) as a Semi-Quantitative Characterization Tool to Assess Extracellular Vesicle-Lipoprotein Binding
Raluca Ghebosu, Jenifer Pendiuk Goncalves, Nur Indah Fitri, et al.
Cancer Immunology, Immunotherapy : CII
|
March 30, 2024
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Andrew N Wilkinson, Rui Chen, Elaina Coleborn, et al.
Nature Communications
|
November 14, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation
Timothy R McCulloch, Gustavo R Rossi, Louisa Alim, et al.
Molecular Therapy Oncolytics
|
October 2, 2023
miR-146a inhibits ovarian tumor growth <i>in vivo</i> via targeting immunosuppressive neutrophils and enhancing CD8<sup>+</sup> T cell infiltration
Rui Chen, Elaina Coleborn, Chintan Bhavsar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy
Louisa Alim, Siddharth Adityan, Rui Chen, et al.
Clinical and Translational Medicine
|
January 7, 2025
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR
Pui Yeng Lam, Natacha Omer, Josh K M Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 3, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
Joshua K M Wong, Pui Yeng Lam, Elaina Coleborn, et al.
Page
of 1